The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state

Asia Pacific Journal of Clinical Nutrition

Volumn 23, Issue 3, 2014, Pages 360-368

  Lopez Legarrea, Patricia ^a,b   Fuller, Nicholas Robert ^c   Zulet, María Angeles ^a,d   Martinez, Jose Alfredo ^a,d   Caterson, Ian Douglas ^c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c UNIVERSITY OF SYDNEY   (Australia)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Dietary strategies; Gut microbiota; Inflammation; Nutrition; Obesity

Indexed keywords

ANIMAL; CARBOHYDRATE DIET; DIET; DIET THERAPY; DRUG EFFECT; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; MEDITERRANEAN DIET; METHODOLOGY; MICROBIOLOGY; MICROFLORA; MOUSE; OBESITY; PHYSIOLOGY; PROTEIN INTAKE; REVIEW;

ANIMALS; DIET; DIET, MEDITERRANEAN; DIETARY CARBOHYDRATES; DIETARY PROTEINS; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; MICE; MICROBIOTA; OBESITY;

EID: 84907371760     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2014.23.3.16     Document Type: Review

References (57)

1. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49:868-913. doi: 10.1080/10408390903372599.
2. de Luis DA, Aller R, Gonzalez Sagrado M, Conde R, Izaola O, de la Fuente B. Serum visfatin levels and metabolic syndrome criteria in obese female subjects. Diabetes Metab Res Rev. 2013;29:576-81. doi: 10.1002/dmrr.2430.
3. Martinez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013; 7:269-80. doi: 10.1038/ismej.2012.104.
4. Martinez JA, Parra MD, Santos JL, Moreno-Aliaga MJ, Marti A, Martinez-Gonzalez MA. Genotype-dependent response to energy-restricted diets in obese subjects; towards personalized nutrition. Asia Pac J Clin Nutr. 2008;17 (Suppl 1) :119-22.
5. Diamant M, Blaak EE, de Vos WM. Do nutrient-gutmicrobiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev. 2011;12:272-81. doi: 10.1111/j.1467-789X.2010.00797.x.
6. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss; links with metabolic and low-grade inflammation markers. Diabetes. 2010;59: 3049-57. doi: 10.2337/db10-0253.
7. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26:5-11. doi: 10.1097/MOG.0b013e328 333d751.
8. Queipo-Ortuno MI, Boto-Ordonez M, Murri M, Gomez- Zumaquero JM, Clemente-Postigo M, Estruch R et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 2012;95:1323-34. doi: 10.3945/ajcn.111.02784.
9. Tachon S, Zhou J, Keenan M, Martin R, Marco ML. The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol. 2012;83:299-309. doi :10. 1111/j.1574-6941.2012.01475.x.
10. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9:577-89. doi: 10.1038/nrgastro.2012.156.
11. Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carteni M et al. Gut-liver axis; the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2012;22:471-6. doi: 10.1016/j.numecd.2012.02.007.
12. Greiner T, Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab. 2011;22:117-23. doi: 10.1016/j.tem.2011.01.002.
13. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90:859-904. doi: 10.1152/physrev.00045.2009.
14. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 2009;9:737-43. doi: 10.1016 /j.coph.2009.06.016
15. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178-84. doi:10.1038/nature11319.
16. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc. 2010;69:434-41. doi: 10.1017/S0029665110001813.
17. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101: 15718-23. doi: 10.1073/pnas.0407076101.
18. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102:11070-5. doi: 10.1073/pnas. 0504978102.
19. Gomez-Hurtado I, Santacruz A, Peiro G, Zapater P, Gutierrez A, Perez-Mateo M et al. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One. 2011;6: e23037. doi: 10.1371/journal.pone.0023037.
20. Nadal I, Santacruz A, Marcos A, Warnberg J, Garagorri M, Moreno LA et al. Shifts in clostridia, bacteroides and immunoglobulin- coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond). 2009;33:758-67. doi: 10.1038/ijo.2008.260.
21. Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010;61:219-25. doi: 10.1016/j.phrs.2009.11.001.
22. Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, Caterson ID et al. Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring). 2011;19:2113-20. doi: 10.1038/oby.2011.68.
23. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes. 2008;57: 1470-81. doi: 10.2337/db07-1403.
24. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72. doi: 10.2337/db07- 1262.
25. Spreadbury I. Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes. 2012;5: 175-89. doi: 10.2147/DMSO.S33473.
26. Cardoso GA, Salgado JM, Cesar Mde C, Donado-Pestana CM. The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women. J Med Food. 2013;16:120-7. doi: 10.1089/jmf.2012.0062
27. Santacruz A, Collado MC, Garcia-Valdes L, Segura MT, Martin-Lagos JA, Anjos T et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83-92. doi: 10.1017/S0007114510000176.
28. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology; human gut microbes associated with obesity. Nature. 2006;444:1022-3. doi: 10.1038/4441022a.
29. Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M. Pilot study; alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther. 2010;32:1307-14. doi: 10.1111/j.1365-2036.2010.047 45.x.
30. Santacruz A, Marcos A, Warnberg J, Marti A, Martin- Matillas M, Campoy C et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring). 2009;17:1906-15. doi: 10.1038/oby. 2009.112
31. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105-8. doi: 10.12968/gasn.2011.9.8.12a.
32. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998; 64:3854-9.
33. Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes. 2010;1:135-7. doi: 10.4161/gmic.1.3.11868.
34. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73:1073-8. doi: 10.1128/AEM.02340-06.
35. Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L et al. High-protein, reduced-carbohydrate weightloss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 2011;93:1062-72. doi: 10.3945/ajcn.110.002188.
36. Brinkworth GD, Noakes M, Clifton PM, Bird AR. Comparative effects of very low-carbohydrate, high-fat and highcarbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr. 2009;101:1493-502. doi: 10.1017/S000711450809465 8.
37. Kim MS, Hwang SS, Park EJ, Bae JW. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep. 2013;5:765-75. doi: 10. 1111/1758-2229.12079.
38. Walton GE, Lu C, Trogh I, Arnaut F, Gibson GR. A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers. Nutr J. 2012;11:36. doi: 10.1186/1475-2891-11- 36.
39. Terpend K, Possemiers S, Daguet D, Marzorati M. Arabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME (R)). Environ Microbiol Rep. 2013;5:595-603. doi: 10.1111/1758-2229.12056.
40. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107: 14691-6. doi: 10.1073/pnas.1005963107.
41. Gogebakan O, Kohl A, Osterhoff MA, van Baak MA, Jebb SA, Papadaki A et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation. 2011;124:2829-38. doi: 10.1161/CIRCULATIO NAHA.111.033274.
42. Alemany M. The problem of nitrogen disposal in the obese. Nutr Res Rev. 2012;25:18-28. doi: 10.1017/S09544224110 00163.
43. Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr. 2000;72:1488-94.
44. Zak-Golab A, Kocelak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G et al. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013;2013:674106. doi: 10.1155/2013/674106.
45. Minocha A. Probiotics for preventive health. Nutr Clin Pract. 2009;24:227-41. doi: 10.1177/0884533608331177
46. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636-43. doi: 10.1038/ejcn.2010.19.
47. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-90. doi: 10.1056/NEJMoa1200303.
48. Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition. 2011;27:733-44. doi: 10.1016/ j.nut.2010.12.006.
49. Lopez-Legarrea P, de la Iglesia R, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr Metab (Lond). 2013;10:22. doi: 10.1186/1743-7075-10-22.
50. Abete I, Goyenechea E, Zulet MA, Martinez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011;21( Suppl 2):B1-15. doi: 10.1016/j.numecd.2011.05.001.
51. Casas-Agustench P, Bullo M, Salas-Salvado J. Nuts, inflammation and insulin resistance. Asia Pac J Clin Nutr. 2010;19:124-30.
52. Bialonska D, Ramnani P, Kasimsetty SG, Muntha KR, Gibson GR, Ferreira D. The influence of pomegranate byproduct and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol. 2010;140:175-82. doi: 10.1016/j.ijfoodmicro.2010.03.038.
53. Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome "at-risk" population. Int J Obes (Lond). 2013;37:216-23. doi: 10.1038/ijo.2012.33.
54. Clemente-Postigo M, Queipo-Ortuno MI, Murri M, Boto- Ordonez M, Perez-Martinez P, Andres-Lacueva C et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res. 2012;53:973-8. doi: 10.1194/jlr.P020909.
55. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86:1286-92. doi: 10.1016/S0084-3741(08)79070-X.
56. Laugerette F, Vors C, Geloen A, Chauvin MA, Soulage C, Lambert-Porcheron S et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem. 2011;22:53-9. doi: 10.1016/ j.jnutbio.2009.11.011.
57. Bomba A, Nemcova R, Gancarcikova S, Herich R, Guba P, Mudronova D. Improvement of the probiotic effect of micro- organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr. 2002;88(Suppl 1):S95-9. doi: 10.1079/BJN2002634.